ORBIT is being funded by a grant of £997,000 from Arthritis Research UK.
Rituximab is being provided free of charge by Roche Pharmaceuticals.
|
||||
ORBIT study – funding |
||||
|
Copyright © 2012 SCAR — All Rights Reserved — Design & Hosting by David Rowbory Site last updated May 18, 2012 @ 7:59 am; This page was last updated April 22, 2010 @ 11:17 am |
||||